Abstract

miR-576-5p represents a promising diagnostic biomarker for OA and alleviates disease progression by targeting KLF10, thereby reducing chondrocyte dysfunction. These results offer new insights into miRNA-based therapeutics for OA.

Affiliated Institutions

Related Publications

Publication Info

Year
2025
Type
article
Volume
26
Issue
1
Pages
1088-1088
Citations
0
Access
Closed

External Links

Citation Metrics

0
OpenAlex

Cite This

Meiling Weng, Zhi‐gang Yang, Xiaoying Feng (2025). Serum miR-576-5p as a novel diagnostic biomarker and therapeutic target for osteoarthritis via targeting KLF10-mediated chondrocyte dysfunction. BMC Musculoskeletal Disorders , 26 (1) , 1088-1088. https://doi.org/10.1186/s12891-025-09322-3

Identifiers

DOI
10.1186/s12891-025-09322-3